Oxidized LDL differentially regulates MMP-1 and TIMP-1 expression in vascular endothelial cells

Atherosclerosis

Volumn 156, Issue 1, 2001, Pages 119-125

  Huang, Yan ^a,b   Song, Lanxi ^b   Wu, Shan ^b   Fan, Fan ^b   Lopes Virella, Maria F ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Endothelium; Metalloproteinases; Oxidized LDL; Tissue inhibitor of metalcloproteinases

Indexed keywords

INTERSTITIAL COLLAGENASE; OXIDIZED LOW DENSITY LIPOPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AORTA; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; UMBILICAL VEIN;

CELLS, CULTURED; COLLAGENASES; CULTURE MEDIA; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, LDL; MATRIX METALLOPROTEINASE 1; TETRADECANOYLPHORBOL ACETATE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UMBILICAL VEINS;

EID: 0035015075     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00638-9     Document Type: Article

References (32)

1. Stetler-Stevenson W.G., Krutzsch H.C., Liotta L.A. Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264:1989;17374-17378.
2. Murphy G., Reynolds J.J., Werb Z. Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture: Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J. Biol. Chem. 260:1985;3079-3083.
3. Clark S.D., Wilhelm S.M., Stricklin G.P., Welgus H.G. Coregulation of collagenase and collagenase inhibitor production by phorbol myristate acetate in human skin fibroblasts. Arch. Biochem. Biophys. 241:1985;36-49.
4. Xu X., Meisel S.R., Ong J.M., Kaul S., Cercek B., Rajavashisth T.B., Sharifi B., Shah R.K. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation. 99:1999;993-998.
5. Li Y.Y., Feldman A.M., Sun Y., McTiernan C.F. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation. 98:1998;1728-1734.
6. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:1994;2493-2503.
7. Huang Y., Mironova M., Lopes-Virella M.F. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19:1999;2640-2647.
8. Huang Y., Ghosh M.J., Lopes-Virella M.F. Transcriptional and post-transcriptional regulation of LDL receptor gene expression in PMA-treated THP-1 cells by LDL-containing immune complexes. J. Lipid Res. 38:1997;110-120.
9. Kim R.S., LaBella F.S. Comparison of analytical methods for monitoring auto-oxidation profiles of authentic lipids. J. Lipid Res. 28:1987;1110-1117.
10. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free. Radic. Res. Commun. 6:1989;67-75.
11. Cominacini L., Garbin U., Davoli A., Micciolo R., Bosello O., Gaviraghi G., Scuro L.A., Pastorino A.M. A simple test for predisposition of LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J. Lipid Res. 32:1991;349-358.
12. Kawamura M., Heinecke J.W., Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J. Clin. Invest. 94:1994;771-778.
13. Fisher C., Gilbertson-Beadling S., Powers E.A., Petzold G., Poorman R., Mitchell M.A. Interstitial collagenase is required for antiogenesis in vitro. Dev. Biol. 162:1994;499-510.
14. George S.J. Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis. Curr. Opin. Lipidol. 9:1998;413-423.
15. Morton L.F., Barnes M.J. Collagen polymorphism in the normal and diseased blood vessel wall. Investigation of collagens types I, III and V. Atherosclerosis. 42:1982;41-51.
16. Hanson A.N., Bentley J.P. Quantitation of type I to type III collagen ratios in small samples of human tendon, blood vessels, and atherosclerotic plaques. Anal. Biochem. 130:1983;32-40.
17. Zhang Y., Cliff W.J., Schoefl G.I., Higgins G. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am. J. Pathol. 143:1993;164-172.
18. Barger A.C., Beeuwkes R., Lainey L.L., Silverman K.V. Hypothesis: vasa vasorum and neovascularisation of human coronary arteries. Possible role in the pathophysiology of atherosclerosis. N. Engl. J. Med. 310:1984;175-177.
19. Groszek E., Grundy S.M. The possible role of the arterial microcirculation in the pathogenesis of atherosclerosis. J. Chronic Dis. 33:1980;679-684.
20. de Boer O.J., van der Wal A.C., Teeling P., Becker A.E. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc. Res. 41:1999;443-449.
21. Chen C.H., Jiang W., Via D.P., Luo S., Li T.R., Lee Y.T., Henry P.D. Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation. 101:2000;171-177.
22. Chen C.H., Henry P.D. Atherosclerosis as a microvascular disease: impaired angiogenesis mediated by suppressed basic fibroblast growth factor expression. Proc. Assoc. Am. Phys. 109:1997;351-361.
23. Ramos M.A., Kuzuya M., Esaki T., Miura S., Satake S., Asai T., Kanda S., Hayashi T., Iguchi A. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler. Thromb. Vasc.Biol. 18:1998;1188-1196.
24. Chen Y.X., Nakashima Y., Tanaka K., Shiraishi S., Nakagawa K., Sueishi K. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler. Thromb. Vasc. Biol. 19:1999;131-139.
25. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77:1999;527-543.
26. Wolfovitz E., Aviram M., Brook J.G., Tatarsky I., Lanir N. Protective effect of low concentrations of oxidized low-density lipoprotein on endothelial cell integrity. J. Cardiovasc. Risk. 2:1995;57-62.
27. Liao J.K., Shin W.S., Lee W.Y., Clark S.L. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270:1995;319-324.
28. Overall C.M. Regulation of tissue inhibitor of metalloproteinase expression. Ann. NY Acad. Sci. 732:1994;51-64.
29. Shapiro S.D., Campbell E.J., Kobayashi D.K., Welgus H.G. Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J. Immunol. 146:1991;2724-2729.
30. Overall C.M., Wrana J.L., Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. J. Biol. Chem. 266:1991;14064-14071.
31. Clark S.D., Kobayashi D.K., Welgus H.G. Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J. Clin. Invest. 80:1987;1280-1288.
32. Maruyama I. Coagulation/fibrinolytic system and platelet in acute coronary syndrome. Jpn. J. Clin. Med. 56:1998;2488-2492.